MannKind Corporation Disappoints With Afrezza Sales; Analysts Lower Expectations
May 11, 2015 at 08:59 AM EDT
The focus of the earnings report was Afrezza; a rapid-acting inhalable insulin for adults with diabetes produced by both MannKind and Sanofi.
